Pluronic® F127-Based Ocular Delivery System Containing Biodegradable Polyisobutylcyanoacrylate Nanocapsules of Pilocarpine

References

• Al Khouri Fallouh, N., Roblot-Treupel, L., Fessi, H., Devissaguet, J-Ph., and Puisieux, F. 1986. Developmen t of a new process for the manufac-ture of polyisobutylcyanoacrylat e nanocapsules. Int. J. Pharm. 28:125–132.
   Google Scholar
• Allemann, E., Gurny, R., and Doelker, E. 1993. Drug-loaded nanoparticles — preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39:173–191.
   Web of Science ®Google Scholar
• Andrieu, V., Fessi, H., Dubrasquet, M., Devissaguet, J-Ph., Puisieux, F., and Benita, S. 1989. Pharmacokineti c evaluation of indomethaci n nanocapsules. Drug Des. Del. 4:295–302.
   Google Scholar
• Aprahamian, M., Michel, C., Humbert, W., and Damge, C. 1987. Transmucosa l passage of polyalkylcyanoacrylat e nanocapsule s as a new drug carrier in the small intestine. Biol. Cell 61:69–76.
   PubMed Web of Science ®Google Scholar
• Blanchard, J., and Harvey, S. 1990. Comparison of ultrafiltration devices for assessing theophylline protein binding. Ther. Drug Monit. 12:398– 403.
   Google Scholar
• Couvreur, P., Kante, B., Roland, M., and Speiser, P. 1979a. Adsorption of anti- neoplastic drugs to polyalkylcyanoacrylat e nanoparticle s and their release in calf serum. J. Pharm. Sci. 68:1521–1524.
   PubMed Web of Science ®Google Scholar
• Couvreur, P., Kante, B., Roland, M., Guiot, P., Baudin, P., and Speiser, P. 1979b. Polycyanoacrylat e nanocapsule s as potential lysosomotropi c carriers: preparation, morphologica l and sorptive properties. J. Pharm. Pharmacol. 31:331–332.
   PubMed Web of Science ®Google Scholar
• Couvreur, P., Kante, B., Lenaerts, V., Scailteur, V., Roland, M., and Speiser, P. 1980. Tissue distribution of anticancer drugs associated to polyalkyl- cyanoacrylat e nanoparticles. J. Pharm. Sci. 69:199–202.
   PubMed Web of Science ®Google Scholar
• Couvreur, P., Kante, B., Grislain, L., Roland, M., and Speiser, P. 1982. Toxicity of polyalkylcyanoacrylat e nanoparticles. II. Doxorubicin loaded nanoparticles. J. Pharm. Sci. 71:790–793.
   PubMed Web of Science ®Google Scholar
• Couvreur, P., Grislain, L., Lenaerts, V., Brasseur, F., Guiot, P., and Biernacki, A. 1986. Biodegradabl e polymeric nanoparticle s as drug carriers for antitu- mor drugs. In Polymeric nanoparticle s and microspheres, ed. P. Guiot and
   Google Scholar
• P. Couvreur, 27– 93. Boca Raton, FL: CRC Press.
   Google Scholar
• Couvreur, P., Tulkens, P., Roland, M., Trouet, A., and Speiser, P. 1977. Nanocap- sules: a new type of lysomotropic carrier. FEBS Lett. 84:331–332.
   PubMedGoogle Scholar
• Damge, C., Michel, C., Aprahamian, M., and Couvreur, P. 1988. New approach for oral administration of insulin with polyalkylcyanoacrylat e nanocapsule s as drug carrier. Diabetes 37:246–251.
   PubMed Web of Science ®Google Scholar
• Damge, C., Aprahamian, M., Balboni, G., Hoeltzel, A., Andrieu, V., and Devissaguet, J-Ph. 1987. Polyalkylcyanoacrylat e nanocapsule s increase the intestinal absorption of a lipophilic drug. Int. J. Pharm. 36:121–125.
   Google Scholar
• Das, S. K., Tucker, I. G., Hill, D. J., and Gangul y, N. 1995. Evaluation of poly(isobutylcyanoacrylate) nanoparticle s for mucoadhesiv e ocular drug de- livery. I. Effect of formulation variables on physicochemica l characteristics of nanoparticles. Pharm. Res. 12:534–540.
   Google Scholar
• Desai, S. D., and Blanchard, J. 1992. A simplified and rapid high performanc e liquid chromatographi c assay for pilocarpine hydrochloride. J. Chromatogr. Sci. 30:149–152.
   Web of Science ®Google Scholar
• Diepold, R., Kreuter, J., Guggenbuhl, P., and Robinson, J. R. 1989. Distribution of poly-hexyl-2-cyan o[3-14 C]acrylate nanoparticles in healthy and inflamed rabbit eyes. Int. J. Pharm. 54:149–153.
   Google Scholar
• Diepold, R., Kreuter, J., Himber, J., Gurny, R., Lee, V. H. L., Robinson, J. R., Saettone, M. F., and Schnaudigel, O. E. 1989. Comparison of different models for the testing of pilocarpine using conventiona l eyedrops and a novel depot formulation (nanoparticles). Graefe’s Arch. Clin. Exp. Ophthalmol. 227:188–193.
   PubMed Web of Science ®Google Scholar
• El-Samaligy, M. S., Rohdevald, P., and Mahmoud, H. A. 1986. Polyalkyl cyanoacrylat e nanocapsules. J. Pharm. Pharmacol. 31:216–218.
   Google Scholar
• Fitzgerald, P., Hadgraft, J., Kreuter, J., and Wilson, C. G. 1987. A gamma- scintigraphic evaluation of microparticulate ophthalmi c delivery systems. Liposomes and nanoparticles. Int. J. Pharm. 40:81–84.
   Web of Science ®Google Scholar
• Gasset, A. R., Hood, C. L., Ellison, E. D., and Kaufman, H. E. 1970. Ocular tolerance to cyanoacrylat e monomer tissue adhesive analogues. Invest. Oph- thalmol. 9:3–11.
   PubMed Web of Science ®Google Scholar
• Harima, T., Kreuter, J., Speiser, P., Boye, T., Gurny, R., and Kubis, A. 1986. Enhancemen t of the myotic response of rabbits with pilocarpine-loade d poly- butylcyanoacrylat e nanoparticles. Int. J. Pharm. 33:187–193.
   Google Scholar
• Kante, B., Couvreur, P., Lenaerts, V., Guiot, P., Roland, M., Baudhuin P., and Speiser, P. 1980. Tissue distribution of 3 H-actinomycin D absorbed on poly- butylcyanoacrylat e nanoparticles. Int. J. Pharm. 7:45–53.
   Google Scholar
• Kreuter, J. 1990. Nanoparticles as bioadhesive ocular drug delivery systems. In Bioadhesive drug delivery systems, ed. V. Lenaerts and R. Gurny, 203–212. Boca Raton, FL: CRC Press.
   Google Scholar
• Kreuter, J., Mills, S. N., Davis, S. S., and Wilson, C. G. 1983. Polybutyl- cyanoacrylat e nanoparticle s for the delivery of [75Se]norcholesterol. Int. J. Pharm. 16:105–113.
   Web of Science ®Google Scholar
• Lenaerts, V., Couvreur, P., Grislain, L., and Maincent, P. 1990. Nanoparti- cles as a gastroadhesive drug delivery system. In Bioadhesive drug deliverysystems, ed. V. Lenaerts and R. Gurny, 93– 105. Boca Raton, FL: CRC Press.
   Google Scholar
• Marchal-Heussler, L., Maincent, P., Hoffman, M., Spittler, J., and Couvreur, P. 1990. Antiglaucomatou s activity of betaxolol chlorhydrat e sorbed onto differ- ent isobutylcyanoacrylat e nanoparticle preparations. Int. J. Pharm. 58:115–122.
   Web of Science ®Google Scholar
• Schmolka, I. R. 1972. Artificial skin. Preparation and properties of pluronic F127 gels for the treatment of burns. J. Biomed. Mater. Res. 6:571–582.
   PubMed Web of Science ®Google Scholar
• Wood, R. W., Li, V. H., Kreuter, J., and Robinson, J. R. 1985. Ocular disposi- tion of polyhexyl-2-cyan o[3-14 C]acrylate nanoparticle s in the albino rabbit. Int. J. Pharm. 23:175–183.
   Web of Science ®Google Scholar